EUVIMEDEUVIMED entdecken
Open Access

Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice

Moeno Kume, Ayesha Ahmad, Kathryn A DeFea, Josef Vagner, Gregory Dussor, Scott Boitano, Theodore J Price

The Journal of Pain · 2023-11 · 24 (11) · 1980-1993

DOI: 10.1016/j.jpain.2023.06.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pain, 2023-11. Verfasst von Moeno Kume und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Center for Advanced Pain Studies, University of Texas at Dallas, Richardson, Texas. Hauptthemen laut MEDLINE: Paclitaxel, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIAID NIH HHS, NIAID DMID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting side effect of cancer therapy. Protease-activated receptor 2 (PAR2) is implicated in a variety of pathologies, including CIPN. In this study, we demonstrate the role of PAR2 expressed in sensory neurons in a paclitaxel (PTX)-induced model of CIPN in mice. PAR2 knockout/wildtype (WT) mice and mice with PAR2 ablated in sensory neurons were treated with PTX administered via intraperitoneal injection. In vivo behavioral studies were done in mice using von Frey filaments and the Mouse Grimace Scale. We then examined immunohistochemical staining of dorsal root ganglion (DRG) and hind paw skin samples from CIPN mice to measure satellite cell gliosis and intra-epidermal nerve fiber (IENF) density. The pharmacological reversal of CIPN pain was tested with the PAR2 antagonist C781. Mechanical allodynia caused by PTX treatment was alleviated in PAR2 knockout mice of both sexes. In the PAR2 sensory neuronal conditional knockout (cKO) mice, both mechanical allodynia and facial grimacing were attenuated in mice of both sexes. In the DRG of the PTX-treated PAR2 cKO mice, satellite glial cell activation was reduced compared to control mice. IENF density analysis of the skin showed that the PTX-treated control mice had a reduction in nerve fiber density while the PAR2 cKO mice had a comparable skin innervation as the vehicle-treated animals. Similar results were seen with satellite cell gliosis in the DRG, where gliosis induced by PTX was absent in PAR cKO mice. Finally, C781 was able to transiently reverse established PTX-evoked mechanical allodynia. PERSPECTIVE: Our work demonstrates that PAR2 expressed in sensory neurons plays a key role in PTX-induced mechanical allodynia, spontaneous pain, and signs of neuropathy, suggesting PAR2 as a possible therapeutic target in multiple aspects of PTX CIPN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelPeripheral Nervous System DiseasesMaleFemaleMiceAnimalsHyperalgesiaReceptor, PAR-2GliosisPainSensory Receptor CellsMice, KnockoutGanglia, Spinal

Stichwörter der Autor:innen

Chemotherapy-induced peripheral neuropathyPaclitaxelProtease-activated receptor 2Satellite cell gliosis

Substanzen

PaclitaxelReceptor, PAR-2

Autor:innen und Institutionen

  • Department of Neuroscience and Center for Advanced Pain Studies, University of Texas at Dallas, Richardson, Texas.
  • PARMedics Incorporated, Temecula, CA.
  • Bio5 Research Institute, University of Arizona, Tucson, Arizona.
  • Bio5 Research Institute, University of Arizona, Tucson, Arizona; Asthma and Airway Disease Research Center, University of Arizona Health Sciences, Tucson, Arizona; Department of Physiology, University of Arizona Health…

Förderung

  • NINDS NIH HHS
  • NIAID NIH HHS
  • NIAID DMID
  • National Institutes of Health
  • NINDS

Zitieren

APA

Kume, M., Ahmad, A., DeFea, K. A., Vagner, J., Dussor, G., Boitano, S., & Price, T. J. (2023). Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice. The Journal of Pain, 24(11), 1980-1993. https://doi.org/10.1016/j.jpain.2023.06.006

Vancouver

Kume M, Ahmad A, DeFea KA, Vagner J, Dussor G, Boitano S, et al. Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice. The Journal of Pain. 2023;24(11):1980-1993. doi:10.1016/j.jpain.2023.06.006

BibTeX
@article{Kume2023,
  author = {Kume, Moeno and Ahmad, Ayesha and DeFea, Kathryn A and Vagner, Josef and Dussor, Gregory and Boitano, Scott and Price, Theodore J},
  title = {Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice},
  journal = {The Journal of Pain},
  year = {2023},
  volume = {24},
  number = {11},
  pages = {1980--1993},
  doi = {10.1016/j.jpain.2023.06.006}
}
Kostenlos starten →